Sun Pharmaceutical Industries Limited (BOM:524715)

BOM:524715 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	114,794	109,290	95,764	84,736	32,727
Depreciation & Amortization	28,692	25,073	24,906	24,771	21,090
Other Amortization	686.5	681.2	661.7	533.4	435.8
Loss (Gain) From Sale of Assets	1,773	235.3	1,662	227.1	1,656
Asset Writedown & Restructuring Costs	-	-	-1.5	-10	-88.7
Loss (Gain) From Sale of Investments	-8,636	-2,514	-921.9	6.2	3,126
Provision & Write-off of Bad Debts	634.1	1,808	905.9	2,071	175.7
Other Operating Activities	-1,074	9,383	-12,248	-6,122	15,133
Change in Accounts Receivable	-20,088	-16,021	3,529	-9,532	-13,423
Change in Inventory	-523	-1,840	5,988	-12,022	3,070
Change in Accounts Payable	10,574	5,280	2,497	11,824	3,699
Change in Other Net Operating Assets	-2,641	9,345	-1,393	-46,888	22,244
Operating Cash Flow	124,192	140,721	121,350	49,593	89,845
Operating Cash Flow Growth	-11.75%	15.96%	144.69%	-44.80%	45.61%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-36,094	-21,286	-22,018	-20,856	-14,950
Sale of Property, Plant & Equipment	961.2	610.1	308.4	210.1	606.1
Cash Acquisitions	-34,051	-2,728	-1,433	-46,858	-7,396
Divestitures	-	-	-	-	238.4
Investment in Securities	-51,897	-38,642	9,325	-16,436	-37,911
Other Investing Activities	7,641	8,698	7,123	4,503	2,101
Investing Cash Flow	-113,441	-53,062	-6,902	-79,437	-57,247

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	1,199	-	1,430	-	1,064
Long-Term Debt Issued	52,022	33,617	45,727	81,598	16,568
Total Debt Issued	53,221	33,617	47,157	81,598	17,632
Short-Term Debt Repaid	-	-482	-	-1,305	-
Long-Term Debt Repaid	-35,616	-44,784	-82,287	-30,010	-45,286
Total Debt Repaid	-35,616	-45,266	-82,287	-31,315	-45,286
Net Debt Issued (Repaid)	17,605	-11,649	-35,130	50,283	-27,654
Common Dividends Paid	-39,339	-36,140	-28,982	-25,189	-21,589
Other Financing Activities	-3,392	-31,270	-2,990	-1,333	-2,692
Financing Cash Flow	-25,126	-79,058	-67,102	23,761	-51,935

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	7,764	1,230	-739.9	1,571	1,274
Miscellaneous Cash Flow Adjustments	1,627	-0.3	12.9	5,667	414.5
Net Cash Flow	-4,983	9,831	46,619	1,155	-17,648

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	88,098	119,435	99,332	28,738	74,895
Free Cash Flow Growth	-26.24%	20.24%	245.65%	-61.63%	49.78%
Free Cash Flow Margin	15.07%	22.72%	20.48%	6.55%	19.38%
Free Cash Flow Per Share	36.72	49.78	41.40	11.98	31.21
Levered Free Cash Flow	59,484	82,397	75,828	7,911	75,693
Unlevered Free Cash Flow	61,602	83,843	77,318	8,986	76,489

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	3,315	2,238	2,190	1,325	732.1
Cash Income Tax Paid	23,139	4,768	15,694	15,098	-9,692
Change in Working Capital	-12,678	-3,236	10,621	-56,618	15,591

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error